Magnetic resonance lymphography findings in patients with biochemical recurrence after prostatectomy and the relation with the Stephenson nomogram
- PMID: 22520482
- DOI: 10.1016/j.ijrobp.2012.02.039
Magnetic resonance lymphography findings in patients with biochemical recurrence after prostatectomy and the relation with the Stephenson nomogram
Abstract
Purpose: To estimate the occurrence of positive lymph nodes on magnetic resonance lymphography (MRL) in patients with a prostate-specific antigen (PSA) recurrence after prostatectomy and to investigate the relation between score on the Stephenson nomogram and lymph node involvement on MRL.
Methods and materials: Sixty-five candidates for salvage radiation therapy were referred for an MRL to determine their lymph node status. Clinical and histopathologic features were recorded. For 49 patients, data were complete to calculate the Stephenson nomogram score. Receiver operating characteristic (ROC) analysis was performed to determine how well this nomogram related to the MRL result. Analysis was done for the whole group and separately for patients with a PSA <1.0 ng/mL to determine the situation in candidates for early salvage radiation therapy, and for patients without pathologic lymph nodes at initial lymph node dissection.
Results: MRL detected positive lymph nodes in 47 patients. ROC analysis for the Stephenson nomogram yielded an area under the curve (AUC) of 0.78 (95% confidence interval, 0.61-0.93). Of 29 patients with a PSA <1.0 ng/mL, 18 had a positive MRL. Of 37 patients without lymph node involvement at initial lymph node dissection, 25 had a positive MRL. ROC analysis for the Stephenson nomogram showed AUCs of 0.84 and 0.74, respectively, for these latter groups.
Conclusion: MRL detected positive lymph nodes in 72% of candidates for salvage radiation therapy, in 62% of candidates for early salvage radiation therapy, and in 68% of initially node-negative patients. The Stephenson nomogram showed a good correlation with the MRL result and may thus be useful for identifying patients with a PSA recurrence who are at high risk for lymph node involvement.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy.Eur Urol. 2015 May;67(5):839-49. doi: 10.1016/j.eururo.2014.03.019. Epub 2014 Mar 26. Eur Urol. 2015. PMID: 24698524 Review.
-
High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy.Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1405-10. doi: 10.1016/j.ijrobp.2011.04.054. Epub 2011 Jun 2. Int J Radiat Oncol Biol Phys. 2012. PMID: 21640507
-
Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.Eur Urol. 2011 Aug;60(2):195-201. doi: 10.1016/j.eururo.2011.01.016. Epub 2011 Jan 18. Eur Urol. 2011. PMID: 21257258
-
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.J Urol. 2003 Nov;170(5):1798-803. doi: 10.1097/01.ju.0000091805.98960.13. J Urol. 2003. PMID: 14532779
-
Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.Int J Radiat Oncol Biol Phys. 1994 Jan 1;28(1):33-7. doi: 10.1016/0360-3016(94)90138-4. Int J Radiat Oncol Biol Phys. 1994. PMID: 7505775 Review.
Cited by
-
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting.Radiol Med. 2022 Feb;127(2):206-213. doi: 10.1007/s11547-021-01435-8. Epub 2021 Nov 30. Radiol Med. 2022. PMID: 34850352
-
Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the block.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Jan;10(1):e1471. doi: 10.1002/wnan.1471. Epub 2017 Apr 6. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018. PMID: 28382713 Free PMC article.
-
Individualized image-based lymph node irradiation for prostate cancer.Nat Rev Urol. 2013 Jul;10(7):376-85. doi: 10.1038/nrurol.2013.111. Epub 2013 May 28. Nat Rev Urol. 2013. PMID: 23712209 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous